| Principal Investigator | Title | Department |
| Chen, Allen | Phase II Trial of Induction Chemotherapy followed by Attenuated Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma associated with Human Papillomavirus (HPV) | Cancer Center |
| Chen, Allen | A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors | Cancer Center |
| Semrad, Thomas | An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 Administered Daily in Patients With Locally Advanced or Metastatic Solid Tumors | Cancer Center |
| Kelly, Karen | CCRC: A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients with, Lymphomas, Chronic Lymphocytic Leukemia and Select Solid Tumors and Varying Degrees of Liver Dysfunction (NCI#9008) | Cancer Center |
| Tuscano, Joseph | CCRC: Phase I Study of the Aurora Kinase A Inhibitor MLN8237 in Combination with the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies (NCI#9091) | Cancer Center |
| Gandara, David |
A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of MetMAb in Combination with Tarceva (Erlotinib) in Patients with Incurable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Met Diagnostic-Positive Tumors who have Received Standard Chemotherapy for Advanced or Metastatic Disease | Cancer Center |
| Semrad, Thomas | A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer | Cancer Center |
| Gandara, David | CCRC: A Phase I Study of ARQ 197 in Combination with IV Topotecan in Advanced Solid Tumors with an Expansion Cohort in Small Cell Lung Cancer (NCI#9152) | Cancer Center |
| Leiserowitz, Gary | A Phase III Trial of Adjuvant Chemotherapy Following Chemo-Radiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemo-Radiation Alone: The OUTBACK Trial | Cancer Center |
| Kelly, Karen | CCRC: Phase I Trial of Oral 5-Fluoro-2-Deoxycytidine With Oral Tetrahydrouridine in Patients with Advanced Solid Tumors (NCI#9127) | Cancer Center |
| Lara, Primo | Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II | Cancer Center |
| Evans, Christopher | A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer | Cancer Center |
| Chan, Andrew | Randomized, double-blind, placebo-controlled study of the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending repeated doses of SAR156597 in patients with idiopathic pulmonary fibrosis (IPF) | UC Davis |
| Chew, Helen | A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness in Women with Early Stage Breast Cancer, Phase III | Cancer Center |
| Anderson, Ivan | Markers of Autonomic Tone and Physical Activity Prescription, A Randomized Control Trial | UC Davis |
| Armstrong, April | A Phase I Randomized Double Blind Sham-Controlled (Placebo) Trial of the Effect of Illumination by the Photometics ScanStar on Human Basal Cell Carcinoma and Immediately Surrounding Tissue Prior to Excision | Cancer Center |
| Chan, Andrew | A 52-Week, Double-Blind, Randomized, Placebo-Controlled Parallel Group Study to Evaluate the Effect of Roflumilast 500 Mcg on Exacerbation Rate in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Treated with a Fixed Dose Combination of Long-Acting Beta Agonist and Inhaled Corticosteroid (LABA/ICS) [ROF-MD-07, Amendment 2, 02 Feb 2012] | UC Davis |
| Valicenti, Richard | Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial | Cancer Center |
| Apperson, Michelle | A Randomized, Double-blind, Double-Dummy, Parallel-Group study to Evaluate the efficacy and safety of Ocrelizumab in comparison to Interferon Beta-1a (Rebif) in patients with Relapsing Multiple Sclerosis
| UC Davis |
| Richman, Carol | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications | Cancer Center |
| Kelly, Karen | UC Davis, Lung Cancer Research Program (LCRP) Biospecimen Collections: 'At Risk' Specimen Collection and Banking Protocol | Cancer Center |
| Fragoso, Ruben | A Phase II Trial of Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastases | Cancer Center |
| Raff, Gary | SHRINERS: Magnetic Mini-Mover Device to Correct Pectus Excavatum | UC Davis |
| Howell, Lydia | Davis Breast Research Program/ATHENA Breast Health Network | Cancer Center |
| Balagtas, Jay | Intensified Methotrexate, Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) | Cancer Center |
For Investigators